93 related articles for article (PubMed ID: 20535790)
1. Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry.
Smith MY; Sobel RE; Wallace CA
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):800-4. PubMed ID: 20535790
[No Abstract] [Full Text] [Related]
2. [Protocol for clinical monitoring of juvenile idiopathic arthritis].
Canhão H; Fonseca JE; Santos MJ; Gomes JA
Acta Reumatol Port; 2007; 32(3):277-81. PubMed ID: 17928788
[TBL] [Abstract][Full Text] [Related]
3. Report on malignancies in the German juvenile idiopathic arthritis registry.
Horneff G; Foeldvari I; Minden K; Moebius D; Hospach T
Rheumatology (Oxford); 2011 Jan; 50(1):230-6. PubMed ID: 21148157
[TBL] [Abstract][Full Text] [Related]
4. Malignancies in juvenile idiopathic arthritis: a preliminary report.
Bernatsky S; Rosenberg AM; Oen KG; Duffy CM; Ramsey-Goldman R; Labrecque J; St Pierre Y; Clarke AE
J Rheumatol; 2011 Apr; 38(4):760-3. PubMed ID: 21239753
[TBL] [Abstract][Full Text] [Related]
5. Update on biologics in juvenile idiopathic arthritis.
Ilowite NT
Curr Opin Rheumatol; 2008 Sep; 20(5):613-8. PubMed ID: 18698187
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
[TBL] [Abstract][Full Text] [Related]
7. Delayed maculopapular, urticarial rash due to infliximab in two children with systemic onset juvenile idiopathic arthritis.
Tutar E; Ekici F; Naçar N; Arici S; Atalay S
Rheumatology (Oxford); 2004 May; 43(5):674-5. PubMed ID: 15103034
[No Abstract] [Full Text] [Related]
8. Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis.
Giannini EH; Ilowite NT; Lovell DJ; Wallace CA; Rabinovich CE; Reiff A; Higgins G; Gottlieb B; Chon Y; Zhang N; Baumgartner SW
Arthritis Rheum; 2010 Nov; 62(11):3259-64. PubMed ID: 20669280
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study.
Dallocchio A; Canioni D; Ruemmele F; Duquesne A; Scoazec JY; Bouvier R; Paraf F; Languepin J; Wouters CH; Guillot M; Quartier P; Bader-Meunier B;
Rheumatology (Oxford); 2010 Sep; 49(9):1694-8. PubMed ID: 20472717
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Ravelli A; Caria MC; Buratti S; Malattia C; Temporini F; Martini A
J Rheumatol; 2001 Apr; 28(4):865-7. PubMed ID: 11327264
[TBL] [Abstract][Full Text] [Related]
11. Juvenile idiopathic arthritis: some progress but still many uncertainties.
Prescrire Int; 2007 Aug; 16(90):168. PubMed ID: 17724846
[TBL] [Abstract][Full Text] [Related]
12. Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis.
Nádia EA; Carvalho JF; Bonfá E; Lotito AP; Silva CA
Isr Med Assoc J; 2009 Oct; 11(10):635-6. PubMed ID: 20077954
[No Abstract] [Full Text] [Related]
13. Methotrexate in juvenile idiopathic arthritis: answers and questions.
Ravelli A; Martini A
J Rheumatol; 2000 Aug; 27(8):1830-3. PubMed ID: 10955319
[No Abstract] [Full Text] [Related]
14. Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis.
Tauber T; Daniel D; Barash J; Turetz J; Morad Y
Rheumatology (Oxford); 2005 Mar; 44(3):405. PubMed ID: 15637094
[No Abstract] [Full Text] [Related]
15. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
16. The German etanercept registry for treatment of juvenile idiopathic arthritis.
Horneff G; Schmeling H; Biedermann T; Foeldvari I; Ganser G; Girschick HJ; Hospach T; Huppertz HI; Keitzer R; Küster RM; Michels H; Moebius D; Rogalski B; Thon A;
Ann Rheum Dis; 2004 Dec; 63(12):1638-44. PubMed ID: 15115709
[TBL] [Abstract][Full Text] [Related]
17. Juvenile idiopathic arthritis: an update.
Olson JC
WMJ; 2003; 102(7):45-50. PubMed ID: 14711024
[TBL] [Abstract][Full Text] [Related]
18. [Accelerated nodulosis during methotrexate therapy for idiopathic juvenile arthritis].
Paúl A; Estanqueiro P; Salgado M
Acta Reumatol Port; 2011; 36(1):83-4. PubMed ID: 21483289
[No Abstract] [Full Text] [Related]
19. High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score.
Bulatović M; Heijstek MW; Verkaaik M; van Dijkhuizen EH; Armbrust W; Hoppenreijs EP; Kamphuis S; Kuis W; Egberts TC; Sinnema G; Rademaker CM; Wulffraat NM
Arthritis Rheum; 2011 Jul; 63(7):2007-13. PubMed ID: 21437879
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
